Long-term efficacy and impact on quality of life of atrial fibrillation catheter ablation in competitive athletes.


Journal

The Journal of sports medicine and physical fitness
ISSN: 1827-1928
Titre abrégé: J Sports Med Phys Fitness
Pays: Italy
ID NLM: 0376337

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 22 12 2021
medline: 2 9 2022
entrez: 21 12 2021
Statut: ppublish

Résumé

Limited data are available on the efficacy of catheter ablation (CA) for sport-associated atrial fibrillation (AF), in particular at long term follow-up. Moreover, the impact of AF CA on Quality of Life (QoL) in this population remains unknown. We aimed to determine AF CA efficacy in athletes, to assess the impact on athletes' QoL (with SF36 score) and on training capabilities in a long-term follow-up (FU). A total of 1215 AF patients' candidates to CA between January 2007 and December 2012, were retrospectively screened. Athletes were defined as patients performing ≥5 h/week of vigorous sports, achieving a total of ≥1500 h lifetime sport activity, for at least one year before AF first symptomatic episode. Out of 1215 AF patients, 133 were considered competitive athletes and underwent CA. Overall, 43% of our cohort showed typical or atypical atrial flutter, which required a more extensive ablation procedure. Before AF, athletes used to practice for a mean of 8.5±2.7 h/week, while after the first AF episode the mean practice duration decreased to 2.8±2.5 h/week. At 10-year follow-up, 83% of athletes did not present any recurrent event, and training capabilities increased up to 5.6±3.6 h/week after the procedure. Moreover, intense physical activity before AF CA was related to long-term AF recurrence rates (P=0.05). QoL scores significantly improved in each single domain (P<0.05). AF CA represents an effective procedure to maintain sinus rhythm in athletes, with a significant improvement in QoL.

Sections du résumé

BACKGROUND BACKGROUND
Limited data are available on the efficacy of catheter ablation (CA) for sport-associated atrial fibrillation (AF), in particular at long term follow-up. Moreover, the impact of AF CA on Quality of Life (QoL) in this population remains unknown. We aimed to determine AF CA efficacy in athletes, to assess the impact on athletes' QoL (with SF36 score) and on training capabilities in a long-term follow-up (FU).
METHODS METHODS
A total of 1215 AF patients' candidates to CA between January 2007 and December 2012, were retrospectively screened. Athletes were defined as patients performing ≥5 h/week of vigorous sports, achieving a total of ≥1500 h lifetime sport activity, for at least one year before AF first symptomatic episode.
RESULTS RESULTS
Out of 1215 AF patients, 133 were considered competitive athletes and underwent CA. Overall, 43% of our cohort showed typical or atypical atrial flutter, which required a more extensive ablation procedure. Before AF, athletes used to practice for a mean of 8.5±2.7 h/week, while after the first AF episode the mean practice duration decreased to 2.8±2.5 h/week. At 10-year follow-up, 83% of athletes did not present any recurrent event, and training capabilities increased up to 5.6±3.6 h/week after the procedure. Moreover, intense physical activity before AF CA was related to long-term AF recurrence rates (P=0.05). QoL scores significantly improved in each single domain (P<0.05).
CONCLUSIONS CONCLUSIONS
AF CA represents an effective procedure to maintain sinus rhythm in athletes, with a significant improvement in QoL.

Identifiants

pubmed: 34931787
pii: S0022-4707.21.13257-8
doi: 10.23736/S0022-4707.21.13257-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1266-1271

Auteurs

Elisabetta Toso (E)

Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, Turin, Italy - elisabetta.toso@gmail.com.
Service of Cardiology, Juventus Football Club, Turin, Italy - elisabetta.toso@gmail.com.

Marco Gagliardi (M)

Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, Turin, Italy.

Mattia Peyracchia (M)

Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, Turin, Italy.

Filippo Angelini (F)

Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, Turin, Italy.

Matteo Anselmino (M)

Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, Turin, Italy.

Federico Ferraris (F)

Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, Turin, Italy.

Carla Giustetto (C)

Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, Turin, Italy.

Marco Scaglione (M)

Division of Cardiology, Cardinal Massaia Hospital, Asti, Italy.

Fiorenzo Gaita (F)

Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, Turin, Italy.
Service of Cardiology, Juventus Football Club, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH